Find below videos and webinars on access and policy developed mainly for patient organisations and advocates. Click here to check full educational resources materials for all areas of work: myeloma and AL amyloidosis, access, patient evidence and capacity building and advocacy.
MPE and ALAN webinar | Patient and clinician involvement in the EU HTA regulation
• Anke-Peggy Holtorf, moderator, Steering Committee member and project coordinator for the Patient and Citizen Involvement in HTA Interest Group, Health Technology Assessment international (HTAi)
• François Houÿez, Treatment Information and Access Director / Health Policy Advisor, European Organisation for Rare Diseases (EURORDIS)
• Mihai Rotaru, Director Market Access, European Federation of Pharmaceutical Industries and Associations (EFPIA)
• Mirjana Huic, HTA independent specialist in HTA/EBM Centre, Croatia
• Robin Doeswijk, Head of European Affairs, European Hematology Association (EHA)[+] Show More
MPE and ALAN webinar | Patient and clinician involvement in the EU HTA regulation
Recording of the webinar held on 26 June 2024 on patient and clinician ...
EHA 2024 | Whose needs exactly? Unmet medical need in the EU pharmaceutical legislation
Maria Cavaller Bellaubi, Patient Engagement and Development Director, ...
EHA 2024 | Fair pricing: Does the value of new medicines in hematology justify the high prices?
Professor Doctor Uyl-de Groot explains fair pricing in haematology ...
MPE/ALAN Webinar | EU HTA
Recording of the webinar held by Myeloma Patients Europe (MPE) and ...
Masterclass 2024 | EU Health Technology Assessment Regulation
Interview filmed with Valentina Strammiello, Director of Programmes, ...
MPE Masterclass 2024 | Cross border medicine and trials access
Claudia Louati, Head of Policy at European Patients' Forum (EPF) ...
Webinar | Basics of medicines pricing in Europe
Recording of the webinar "Basics of medicines pricing in Europe" held ...
ESMO 2023 | Access inequalities to modern treatments
MPE´s Co-Chief Executive Officer, Kate Morgan, explains the access ...
ESMO 2023 | Patient engagement and collaboration with national regulatory agencies
MPE Board President Lise-Lott Eriksson explains patient engagement and ...
Masterclass 2023 | Improving access to clinical trials in Central Eastern European (CEE) countries
Prof. Dr. Roman Hajek, Department of Hematooncology, University ...
Masterclass 2023 | Panel discussion on sequencing: Optimising the myeloma Pathway
Eric Low, Eric Low Consulting, explains what was discussed during the ...
Masterclass 2023 | Health Technology Assessment (HTA)
Neil Bertelsen, Steering Committee Member and past Chair of HTAi PCIG, ...
MPE Webinar: Access Barriers to Clinical Trials in CEE Countries
This is a recording of Prof. Dr. Karanfilski giving a summary of the ...
MPE Masterclass 2022 | Patient group involvement in HTA
Neil Bertelsen, Steering Committee Member/Past Chair HTAi Patient and ...
MPE Masterclass 2021 | Access to new treatments in CEE countries
Recording of the session "Access to new treatments. A clinical ...
1
of 2